Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2010
10/28/2010US20100273809 Method and composition for treating an alpha adrenoceptor-mediated condition
10/28/2010US20100273753 Organic compounds
10/28/2010US20100273709 Composition Comprising Desmopressin
10/28/2010US20100272820 Preparation Method of Sustained-Release Microcapsules Having Good Initial Burst Inhibiting Property and the Microcapsules Thereby
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2756074A1 Fast-acting insulin formulation
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1871005B 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/27/2010CN1697839B Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
10/27/2010CN1668303B Selective estrogen receptor modulators containing a phenylsulfonyl group
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820706 Inducing ovulation in a female suffering from anovulatory infertility by administering two or more daily doses of at least one aromatase inhibitor
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820400 Tumor-associated marker
10/26/2010CA2498267C Method for treating erectile dysfunction and increasing libido in men
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010120889A1 Treatment of metabolic syndrome with cyclic amides
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010097576A9 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010US20100267822 Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases
10/21/2010US20100267748 HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORS
10/21/2010US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267615 Methods for treatment and/or prevention of a disease associated with vascular leak
10/21/2010US20100266705 Nanoparticulate megestrol formulations
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266665 Fenugreek Flour for Incorporating Into Food Products
10/21/2010US20100266595 Treatment of insulin-resistant disorders
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/20/2010EP2240474A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/20/2010EP2240198A1 Composition for absorption through mucous tissue
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010CN101868243A Aromatase inhibitor
10/20/2010CN101863971A Metastin derivatives and use thereof
10/20/2010CN101862317A Pregabalin derivatives for the treatment of fibromyalgia and other disorders
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010CA2456547C Process for preparing inhalable powders
10/14/2010WO2010118025A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group
10/14/2010WO2010115615A1 Improved glucocorticoid therapy
10/14/2010WO2010115556A1 Compounds and uses
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261693 Method for treating cushing's syndrome
10/14/2010US20100261692 Method of manufacture of compressed pharmaceutical formulation containing tibolone
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100260681 Adrenocorticotropic hormone analogs and related methods
10/14/2010CA2757858A1 Improved glucocorticoid therapy
10/13/2010EP2238151A1 17-hydroxy-19-nor-21-carboxylic acid-steroid -lactone derivative, use thereof, and medicament containing the derivative
10/13/2010EP2238150A1 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE
10/13/2010EP2238149A2 19-nor-steroid derivatives with a 15 ,16 -methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
10/13/2010EP2238148A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/13/2010EP2238147A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/13/2010EP2134720B1 Heterocyclic spiro-compounds
10/13/2010EP1255553B1 Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN101861152A DEHA compositions for treating menopause
10/13/2010CN101861140A Acid containing lipid formulations
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101856395A Method for preparing cistanche deserticola crude drug for decoction
10/13/2010CN101856363A Application of Bortezomib in preparing drugs for curing POEMS syndrome
10/13/2010CN101856116A Application of coumaroyl spermidine type compounds or plant extracts thereof
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812036 Androgens
10/12/2010US7811984 BV8 nucleic acids and polypeptides with mitogenic activity
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010111845A1 A high specific activity human menopausal gonadotropin, preparation method and use thereof
10/07/2010WO2010078833A8 Modified sodium-montmorillonite, preparing method and uses thereof
10/07/2010US20100256227 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor
10/07/2010US20100256226 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100256060 Peptide pharmaceuticals for nasal delivery
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255100 Stabilized protein crystals, formulations comprising them and methods of making them
10/07/2010US20100255085 Progesterone Solutions for Increased Bioavailability
10/07/2010US20100255072 Dermal delivery device with in situ seal
10/07/2010US20100255059 Artificial micro-gland
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254984 Fusion constructs containing active sections of tnf ligands
10/07/2010CA2757188A1 Pyrimidine compound
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235035A2 C-21 thioethers as glucocorticoid receptor agonists
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 290